We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
207 hedge funds and large institutions have $839M invested in Amphastar Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 80 increasing their positions, 81 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
196% more call options, than puts
Call options by funds: $2.77M | Put options by funds: $935K
1% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 81
1.67% less ownership
Funds ownership: 62.58% → 60.9% (-1.7%)
7% less funds holding
Funds holding: 222 → 207 (-15)
21% less capital invested
Capital invested by funds: $1.06B → $839M (-$223M)
40% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 35
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
207
Holders Change
-15
Holders Change %
-6.76%
% of All Funds
3.57%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
80
Reduced
81
Closed
35
Calls
$2.77M
Puts
$935K
Net Calls
+$1.83M
Net Calls Change
+$56.5M
